Clinical Trial Update: An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy

View source ↗

Summary

An observational study evaluating epoetin beta (NeoRecormon) for treating anemia in cancer patients undergoing chemotherapy has completed, and the results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED | Results posted: 2016-08-19